Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in 2022 to US$ 46.72 million by 2030. It is estimated to grow at a CAGR of 7.8% from 2022 to 2030.
Growing Research and Development Activities Drive Middle East & Africa Deep Brain Simulation Market
Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson's patients compared to traditional methods. Abbott's Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects. Therefore, technological advancements in DBS are expected to create opportunities for the global deep brain stimulation market during the forecast period.
Middle East & Africa Deep Brain Simulation Market Overview
As per an article published in the Journal of Family Medicine and Primary Care, titled "Public knowledge and awareness about Parkinson's disease in Saudi Arabia," the prevalence of PD in Saudi Arabia has been estimated to be 27 per 100,000 population. According to United Nations Population Fund Report 2021, Saudi Arabia is undergoing a demographic transition as the number of persons aged 60 and above is expected to increase from 2 million (5.9% of the total population) in 2020 to 10.5 million (23.7%) by 2050. The prevalence rate of neurological diseases is high among older adults, affecting 5-55% of people aged 55 and older. They are prone to adverse health outcomes, including mortality, disability, institutionalization, and hospitalization, as DBS is the most commonly performed surgical treatment for Parkinson’s. Thus, the growing aging population and rising prevalence of PD are expected to boost the deep brain stimulator market in Saudi Arabia during the forecast period.
Middle East & Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Deep Brain Simulation Market Segmentation
The Middle East & Africa deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the Middle East & Africa deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on application, the Middle East & Africa deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on end user, the Middle East & Africa deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on country, the Middle East & Africa deep brain simulation market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2022, Saudi Arabia registered the largest share in the Middle East & Africa deep brain simulation market.
Abbott, Medtronic, Boston Sci, and Aleva Neurotherapeutics SA are some of the leading companies operating in the Middle East & Africa deep brain simulation market.
Growing Research and Development Activities Drive Middle East & Africa Deep Brain Simulation Market
Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson's patients compared to traditional methods. Abbott's Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects. Therefore, technological advancements in DBS are expected to create opportunities for the global deep brain stimulation market during the forecast period.
Middle East & Africa Deep Brain Simulation Market Overview
As per an article published in the Journal of Family Medicine and Primary Care, titled "Public knowledge and awareness about Parkinson's disease in Saudi Arabia," the prevalence of PD in Saudi Arabia has been estimated to be 27 per 100,000 population. According to United Nations Population Fund Report 2021, Saudi Arabia is undergoing a demographic transition as the number of persons aged 60 and above is expected to increase from 2 million (5.9% of the total population) in 2020 to 10.5 million (23.7%) by 2050. The prevalence rate of neurological diseases is high among older adults, affecting 5-55% of people aged 55 and older. They are prone to adverse health outcomes, including mortality, disability, institutionalization, and hospitalization, as DBS is the most commonly performed surgical treatment for Parkinson’s. Thus, the growing aging population and rising prevalence of PD are expected to boost the deep brain stimulator market in Saudi Arabia during the forecast period.
Middle East & Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Deep Brain Simulation Market Segmentation
The Middle East & Africa deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the Middle East & Africa deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on application, the Middle East & Africa deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on end user, the Middle East & Africa deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Middle East & Africa deep brain simulation market.
Based on country, the Middle East & Africa deep brain simulation market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2022, Saudi Arabia registered the largest share in the Middle East & Africa deep brain simulation market.
Abbott, Medtronic, Boston Sci, and Aleva Neurotherapeutics SA are some of the leading companies operating in the Middle East & Africa deep brain simulation market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Middle East & Africa Deep Brain Stimulation Market, by Region (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET LANDSCAPE
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 Global Deep Brain Stimulation and Lesion Surgeries 2022, By Volume
4.3.4 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. DEEP BRAIN SIMULATION MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
7. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
7.1 Overview
7.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
8.1 Overview
8.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson's Disease
8.3.1 Overview
8.3.2 Parkinson's Disease: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's Disease
8.5.1 Overview
8.5.2 Alzheimer's Disease: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
9.1 Overview
9.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
10. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - COUNTRY ANALYSIS
10.1 Overview
10.1.1 Middle East & Africa Middle East & Africa Deep Brain Simulation Market by Country
10.1.1.1 UAE
10.1.1.1.1 Overview
10.1.1.1.2 UAE Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.3 UAE Deep Brain Simulation Market, by Product
10.1.1.1.4 UAE Deep Brain Simulation Market, by Application
10.1.1.1.5 UAE Deep Brain Simulation Market, by End User
10.1.1.2 Saudi Arabia
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Saudi Arabia Deep Brain Simulation Market, by Product
10.1.1.2.4 Saudi Arabia Deep Brain Simulation Market, by Application
10.1.1.2.5 Saudi Arabia Deep Brain Simulation Market, by End User
10.1.1.3 South Africa
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 South Africa Deep Brain Simulation Market, by Product
10.1.1.3.4 South Africa Deep Brain Simulation Market, by Application
10.1.1.3.5 East & Africa Deep Brain Simulation Market, by End User
10.1.1.4 Rest of Middle East & Africa
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of Middle East & Africa Deep Brain Simulation Market, by Product
10.1.1.4.4 Rest of Middle East & Africa Deep Brain Simulation Market, by Application
10.1.1.4.5 Rest of Middle East & Africa Deep Brain Simulation Market, by End User
11. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Deep Brain Stimulation Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET, KEY COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Aleva Neurotherapeutics SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boston Scientific Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Middle East & Africa Deep Brain Stimulation Market, by Region (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET LANDSCAPE
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 Global Deep Brain Stimulation and Lesion Surgeries 2022, By Volume
4.3.4 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. DEEP BRAIN SIMULATION MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
7. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
7.1 Overview
7.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
8.1 Overview
8.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson's Disease
8.3.1 Overview
8.3.2 Parkinson's Disease: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's Disease
8.5.1 Overview
8.5.2 Alzheimer's Disease: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
9.1 Overview
9.2 Middle East & Africa Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
10. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET - COUNTRY ANALYSIS
10.1 Overview
10.1.1 Middle East & Africa Middle East & Africa Deep Brain Simulation Market by Country
10.1.1.1 UAE
10.1.1.1.1 Overview
10.1.1.1.2 UAE Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.3 UAE Deep Brain Simulation Market, by Product
10.1.1.1.4 UAE Deep Brain Simulation Market, by Application
10.1.1.1.5 UAE Deep Brain Simulation Market, by End User
10.1.1.2 Saudi Arabia
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Saudi Arabia Deep Brain Simulation Market, by Product
10.1.1.2.4 Saudi Arabia Deep Brain Simulation Market, by Application
10.1.1.2.5 Saudi Arabia Deep Brain Simulation Market, by End User
10.1.1.3 South Africa
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 South Africa Deep Brain Simulation Market, by Product
10.1.1.3.4 South Africa Deep Brain Simulation Market, by Application
10.1.1.3.5 East & Africa Deep Brain Simulation Market, by End User
10.1.1.4 Rest of Middle East & Africa
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of Middle East & Africa Deep Brain Simulation Market, by Product
10.1.1.4.4 Rest of Middle East & Africa Deep Brain Simulation Market, by Application
10.1.1.4.5 Rest of Middle East & Africa Deep Brain Simulation Market, by End User
11. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Deep Brain Stimulation Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. MIDDLE EAST & AFRICA DEEP BRAIN SIMULATION MARKET, KEY COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Aleva Neurotherapeutics SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boston Scientific Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
